Back
Pros Holdings Vs. Kymera Therapeutics Industry Stock Comparison
Buy
53
PRO
Pros Holdings
Last Price:
$14.37
Seasonality Move:
7.34%
Sell
33
KYMR
Kymera Therapeutics
Last Price:
$39.93
Seasonality Move:
-2.33%
Buy
53
Pros Holdings (PRO)
is a Buy
Is Pros Holdings a Buy, Sell or Hold?
-
The current Pros Holdings [PRO] share price is $14.33. The Score for PRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
PRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $39.87. The Score for KYMR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRO Stock Price Chart
What is Pros Holdings's stock price today?
-
The Pros Holdings share price today is $14.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRO is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $39.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.89 | Buy |
Relative Strength Index (14 RSI): | 37.75 | Sell |
Chaikin Money Flow: | -69178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.77 - 16.17) | Sell |
Bollinger Bands (100): | (15.13 - 18.63) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.79 | Buy |
Relative Strength Index (14 RSI): | 37.76 | Sell |
Chaikin Money Flow: | 839243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.68 - 46.1) | Sell |
Bollinger Bands (100): | (28.65 - 45.39) | Buy |
PRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.65 | Sell |
20-day SMA: | 15.38 | Sell |
50-day SMA: | 16.03 | Sell |
200-day SMA: | 19.97 | Sell |
8-day EMA: | 13.69 | Buy |
20-day EMA: | 9.89 | Buy |
50-day EMA: | 5.31 | Buy |
200-day EMA: | 1.56 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.25 | Sell |
20-day SMA: | 43.63 | Sell |
50-day SMA: | 44.84 | Sell |
200-day SMA: | 39.18 | Buy |
8-day EMA: | 38.09 | Buy |
20-day EMA: | 27.63 | Buy |
50-day EMA: | 14.86 | Buy |
200-day EMA: | 4.36 | Buy |
Pros Holdings Earnings Growth & PRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.06 per share, an increase this year of $0.27 per share, and an increase next year of $0.22 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.27 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.71 per share.
Pros Holdings Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |